Table 3.
AMH Levels of Age-Stratified Groups of PCOS Patients and Controls
| Age (years) | N | AMH (ng/mL) | P | ||
|---|---|---|---|---|---|
| PCOS | Controls | PCOS | Controls | ||
| 16–19 | 226 | 103 | 8.84±4.52 | 5.98±3.62 | <0.01 |
| 20–25 | 775 | 218 | 9.00±4.89 | 6.14±3.31 | <0.01 |
| 26–29 | 630 | 310 | 8.10±4.56 | 5.03±3.11 | <0.01 |
| N | 1631 | 631 | 8.63±4.73 | 5.57±3.31 | |
Notes: The table shows the AMH levels in different age groups of PCOS patients and controls. The change in AMH with age in PCOS is roughly the same as that in controls, reaching the highest level in the 20–25-year-old age group.
Abbreviations: AMH, anti-Mullerian hormone; PCOS, polycystic ovary syndrome.